HuagongsheHuagongshe Chemistry Print Report · For research reference only
N-(1-Cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide → N-{1-[3-(4-Bromo-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-4-yl}-N-cyclopropyl-4-oxazol-5-yl-benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | N-(1-Cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide | HCID 86678209 | — |
| Reactant | HCID 178513245 | HCID 178513245 | — |
| Product | N-{1-[3-(4-Bromo-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-4-yl}-N-cyclopropyl-4-oxazol-5-yl-benzamide | HCID 60194755 | — |
Reaction Steps
The title compound is prepared from N-(1-cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide and 4-bromo-N-hydroxy-benzamidine following a procedure analogous to that described in Example 1. LC (method 6): tR=2.08 min; Mass spectrum (ESI+): m/z=534/536 (Br) [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08822471B2 |
| Source dataset | uspto-grants-2014_09 |
| ORD ID | ord-5445f4bb82114bd2ad450dccf45b281e |
| Source note | uspto-grants-2014_09 |